Structure Database (LMSD)
LMSD: Structure-based search results
| LM_ID | Common Name | Systematic Name | Formula | Mass | Main Class | Sub Class |
|---|---|---|---|---|---|---|
| LMFA04010003 | 13-F4-NeuroP | (4Z,7Z,10Z,14E)-15-(2-ethyl-3,5- dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010075 | ent-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010076 | ent-16-epi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010077 | ent-16-epi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010078 | ent-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010079 | 13-epi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010080 | 13,16-diepi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010081 | 13,16-diepi-13-F4c-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010082 | 13-epi-13-F4t-NeuroP | (R,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010083 | ent-13-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010084 | ent-13,16-diepi-13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010085 | ent-13,16-diepi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010086 | ent-13-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3S,5R)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010087 | 13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2S,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010088 | 16-epi-13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1R,2R,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010089 | 16-epi-13-F4c-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2S,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |
| LMFA04010090 | 13-F4t-NeuroP | (S,4Z,7Z,10Z,14E)-15-((1S,2R,3R,5S)-2- ethyl-3,5-dihydroxycyclopentyl)-13- hydroxypentadeca-4,7,10,14-tetraenoic acid | C22H34O5 | 378.2406 | Docosanoids [FA04] | Neuroprostanes [FA0401] |